CBD has solid evidence for rare pediatric epilepsies, preliminary signal in anxiety and psychosis, and insufficient evidence for most conditions it’s marketed for.
‘Depression is inflammation’ holds for a subgroup of patients, not for everyone. Community-sample and twin data weaken the broader version of the claim.
CBT-I beats sleep medications long-term and self-help versions work too. Sleep hygiene alone isn’t enough — the two are routinely conflated.
Exercise reliably reduces depression and anxiety symptoms — but the cardio-vs-resistance gap and antidepressant parity claims are overstated.
Depression is a complex mental health disorder that affects millions of people worldwide, presenting a significant challenge for current medical treatments due to various side effects and drug resistances associated with conventional antidepressants. In response, researchers have turned their attention to natural plant polysaccharides, which have shown promising antidepressant effects through diverse mechanisms. This exploration …
Depression, a pervasive global health issue, significantly impairs quality of life and burdens the healthcare system. Despite the availability of numerous antidepressants, their effectiveness is often limited, pushing researchers to explore alternative treatments. Berberine, a natural compound with a diverse pharmacological profile, has shown promising antidepressant effects, offering a potential complementary or alternative approach to …
In a comprehensive study conducted within Shanghai’s Songjiang University Town, researchers embarked on an ambitious project to unravel the complexities of depressive symptoms among college students and to dissect the interplay between these symptoms and physical activity levels. Their meticulous approach utilized a blend of diagnostic tools and questionnaires to categorize depressive symptoms and measure …